At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 249 enrolled
Drug / intervention
infliximabdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of Infliximab (REMICADE�) Induction Therapy in Patients With Plaque-type Psoriasis
In Brief
A Phase 2 clinical trial evaluating infliximab for Psoriasis. Completed, enrolled 249 participants.
Detailed Summary
The purpose of the study is to evaluate the effectiveness and safety of infliximab (Remicade) in patients with plaque-type psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
Countries--
Collaborators--
Timeline
Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Study CompletionJan 2003
First PostedOct 2005
TodayJul 2026
First PostedOct 3, 2005
Study CompletionJan 1, 2003
TodayJul 2, 2026
Posted 20.7 years ago
Interventions
infliximabdrug